Emily Stein, PhD

Original Contribution

First Clinical Experience With Targeted REnal Nerve Demodulation (TREND-1) Using a Neurotropic Agent for the Treatment of Sympathetic Hypertension

01/15/2017

Mark Wholey , MD;

Emily Stein , PhD;

Venkateswara Rao , PhD;

Nicholas Kipshidze , MD, PhD;

Michael H. Wholey , MD, MBA;

Konstantin Kipiani , MD;

Horst Sievert , MD, FESC, FACC, FSCAI;

Vakhtang Kipiani , MD;

Tea Mukhuradze , MD;

An evaluation of the feasibility and safety of a novel targeted neuromodulatory treatment for sympathetic hypertension involving a one-time local injection of neurotropic agents near renal nerves.

An evaluation of the feasibility...

01/15/2017

Journal of Invasive Cardiology

Featured Webinar

Implementing ERAS Protocols Throughout Patient Peri-Op Journey: Reductions in Complications

Upcoming Events

December 4 ⁠–⁠ December 5

Great Debates & Updates in Diabetic Foot

December 6 ⁠–⁠ December 7

December 9 ⁠–⁠ December 11

December 12 ⁠–⁠ December 13

December 14 ⁠–⁠ December 15

February 2 ⁠–⁠ February 5

February 27 ⁠–⁠ March 1

March 17 ⁠–⁠ March 19

March 27 ⁠–⁠ March 30

See Full Calendar

Emily Stein, PhD

Featured Webinar

Upcoming Events

Specialties

Events

Year Round Education

HMP Global Products